Insider Transactions in Q1 2023 at Cme Group Inc. (CME)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 28
2023
|
William R Shepard Director |
BUY
Open market or private purchase
|
Indirect |
194
+0.08%
|
$36,084
$186.45 P/Share
|
|
Mar 27
2023
|
William R Shepard Director |
BUY
Open market or private purchase
|
Indirect |
297
+0.12%
|
$54,945
$185.32 P/Share
|
|
Mar 27
2023
|
William R Shepard Director |
BUY
Open market or private purchase
|
Direct |
13
+0.58%
|
$2,405
$185.32 P/Share
|
|
Mar 16
2023
|
Ken Vroman Chief Transformation Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
108
-0.72%
|
$20,196
$187.21 P/Share
|
|
Mar 15
2023
|
Jonathan L Marcus Sr MD General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
2,636
+50.0%
|
$479,752
$182.67 P/Share
|
|
Mar 15
2023
|
Lynne Fitzpatrick Sr MD Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
171
-1.47%
|
$31,122
$182.67 P/Share
|
|
Mar 15
2023
|
Suzanne Sprague Sr MD Global Head of Clearing |
SELL
Payment of exercise price or tax liability
|
Direct |
171
-2.87%
|
$31,122
$182.67 P/Share
|
|
Mar 15
2023
|
Timothy Francis Mc Court Sr MD Global Head Equity & FX |
SELL
Payment of exercise price or tax liability
|
Direct |
204
-3.82%
|
$37,128
$182.67 P/Share
|
|
Feb 16
2023
|
Bryan T Durkin Director |
SELL
Bona fide gift
|
Direct |
1,367
-1.99%
|
-
|
|
Jan 18
2023
|
William R Shepard Director |
BUY
Open market or private purchase
|
Indirect |
1,243
+0.5%
|
$217,525
$175.98 P/Share
|
|
Jan 18
2023
|
William R Shepard Director |
BUY
Open market or private purchase
|
Direct |
54
+2.38%
|
$9,450
$175.98 P/Share
|